PubMed

The prosurvival activity of ascites against TRAIL is associated with a shorter disease-free interval in patients with ovarian cancer.

Lane D, Matte I, Rancourt C, Piché A.

J Ovarian Res. 2010 Jan 18;3:1.PMID: 20157422 [PubMed - in process]Free PMC ArticleFree textRelated citations

Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells.

Lane D, Robert V, Grondin R, Rancourt C, Piché A.

Int J Cancer. 2007 Sep 15;121(6):1227-37.PMID: 17534891 [PubMed - indexed for MEDLINE]Related citations

Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.

Piver MS.

Oncologist. 1996;1(5):326-330.PMID: 10388011 [PubMed - as supplied by publisher]Free ArticleRelated citations

The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.

Nguyen DM, Yeow WS, Ziauddin MF, Baras A, Tsai W, Reddy RM, Chua A, Cole GW Jr, Schrump DS.

Cancer J. 2006 Jul-Aug;12(4):257-73.PMID: 16925970 [PubMed - indexed for MEDLINE]Related citations

Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells.

Griffin D, Wittmann S, Guo F, Nimmanapalli R, Bali P, Wang HG, Bhalla K.

Gynecol Oncol. 2003 Apr;89(1):37-47.PMID: 12694652 [PubMed - indexed for MEDLINE]Related citations

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

Cuello M, Ettenberg SA, Nau MM, Lipkowitz S.

Gynecol Oncol. 2001 Jun;81(3):380-90.PMID: 11371126 [PubMed - indexed for MEDLINE]Related citations

Enhancement of Apo2L/TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis in non-small cell lung cancer cell lines by chemotherapeutic agents without correlation to the expression level of cellular protease caspase-8 inhibitory protein.

Frese S, Brunner T, Gugger M, Uduehi A, Schmid RA.

J Thorac Cardiovasc Surg. 2002 Jan;123(1):168-74.PMID: 11782771 [PubMed - indexed for MEDLINE]Related citations

Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.

Lane D, Cartier A, L'Espérance S, Côté M, Rancourt C, Piché A.

Gynecol Oncol. 2004 Jun;93(3):594-604.PMID: 15196850 [PubMed - indexed for MEDLINE]Related citations

Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs.

Tomek S, Horak P, Pribill I, Haller G, Rössler M, Zielinski CC, Pils D, Krainer M.

Gynecol Oncol. 2004 Jul;94(1):107-14.PMID: 15262127 [PubMed - indexed for MEDLINE]Related citations

Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells.

Abdollahi T, Robertson NM, Abdollahi A, Litwack G.

Apoptosis. 2005 Dec;10(6):1383-93.PMID: 16215677 [PubMed - indexed for MEDLINE]Related citations

Bcl-X(L) is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells.

Dodier P, Piché A.

Gynecol Oncol. 2006 Feb;100(2):254-63. Epub 2005 Sep 26.PMID: 16188300 [PubMed - indexed for MEDLINE]Related citations

Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells.

Wahl H, Tan L, Griffith K, Choi M, Liu JR.

Gynecol Oncol. 2007 Apr;105(1):104-12. Epub 2006 Dec 15.PMID: 17174384 [PubMed - indexed for MEDLINE]Related citations

Trail activity in human ovarian cancer cells: potentiation of the action of cytotoxic drugs.

Vignati S, Codegoni A, Polato F, Broggini M.

Eur J Cancer. 2002 Jan;38(1):177-83.PMID: 11750848 [PubMed - indexed for MEDLINE]Related citations

Optimal chemotherapy treatment for women with recurrent ovarian cancer.

Fung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P.

Curr Oncol. 2007 Oct;14(5):195-208.PMID: 17938703 [PubMed]Free PMC ArticleFree textRelated citations

Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.

Menendez JA, Vellon L, Colomer R, Lupu R.

Int J Cancer. 2005 May 20;115(1):19-35.PMID: 15657900 [PubMed - indexed for MEDLINE]Related citations

A systematic overview of chemotherapy effects in ovarian cancer.

Högberg T, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):340-60. Review.PMID: 11441940 [PubMed - indexed for MEDLINE]Related citations

Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel.

Asakuma J, Sumitomo M, Asano T, Asano T, Hayakawa M.

Cancer Res. 2003 Mar 15;63(6):1365-70.PMID: 12649200 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.

Azuhata T, Scott D, Griffith TS, Miller M, Sandler AD.

J Pediatr Surg. 2006 Aug;41(8):1431-40.PMID: 16863850 [PubMed - indexed for MEDLINE]Related citations

Inhibition of phosphatidylinositol 3'-kinase increases efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.

Hu L, Hofmann J, Lu Y, Mills GB, Jaffe RB.

Cancer Res. 2002 Feb 15;62(4):1087-92.PMID: 11861387 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.

Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM.

Int J Cancer. 2002 Jun 1;99(4):491-504.PMID: 11992538 [PubMed - indexed for MEDLINE]Related citations